Biomimetic nanoparticles for effective mild temperature photothermal therapy and multimodal imaging
- 12 May 2022
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 347, 270-281
Abstract
No abstract availableKeywords
Funding Information
- Basic and Applied Basic Research Foundation of Guangdong Province (2021A1515010302)
- Basic and Applied Basic Research Foundation of Guangdong Province (2021A1515010635)
- National Natural Science Foundation of China (51803087)
This publication has 54 references indexed in Scilit:
- A continuous tri-phase transition effect for HIFU-mediated intravenous drug deliveryBiomaterials, 2014
- Modelling the efficacy of hyperthermia treatmentJournal of The Royal Society Interface, 2013
- Magnetically Triggered Dual Functional Nanoparticles for Resistance‐Free Apoptotic HyperthermiaAngewandte Chemie International Edition, 2013
- Targeting heat shock proteins in cancerCancer Letters, 2013
- Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathwaysBiomaterials, 2013
- Hydrophilic Cu9S5 Nanocrystals: A Photothermal Agent with a 25.7% Heat Conversion Efficiency for Photothermal Ablation of Cancer Cells in VivoACS Nano, 2011
- Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancerNanomedicine: Nanotechnology, Biology and Medicine, 2011
- Targeting mitochondria for cancer therapyNature Reviews Drug Discovery, 2010
- The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisitedNature Reviews Cancer, 2003
- Lonidamine: a non-mutagenic antitumor agentCarcinogenesis, 1990